Intravitreal application of AAV-BDNF or mutant AAV-CRMP2 protects retinal ganglion cells and stabilizes axons and myelin after partial optic nerve injury
Wissam Chiha, Carole A. Bartlett, Steven Petratos, Melinda Fitzgerald, Alan R. Harvey
Topics & Concepts
Optic nerveMyelinNeuroscienceRetinal ganglion cellRetinaNeuroprotectionNeurotrophic factorsBiologyBrain-derived neurotrophic factorCiliary neurotrophic factorRetinal degenerationCentral nervous systemReceptorBiochemistryAxon Guidance and Neuronal SignalingNerve injury and regenerationNeurogenesis and neuroplasticity mechanisms